Inner Mongolia OJing Science & Technology Co., Ltd.
SZSE:001269.SZ
42.29 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 3,129.349 | 1,433.844 | 848.401 | 559.887 | 573.756 | 548.116 | 344.931 | 216.227 | 113.41 | 79.651 | 84.882 |
| Cost of Revenue
| 2,240.298 | 1,034.14 | 625.624 | 408.567 | 441.888 | 420.329 | 223.589 | 141.778 | 71.691 | 56.13 | 57.078 |
| Gross Profit
| 889.051 | 399.704 | 222.777 | 151.319 | 131.868 | 127.787 | 121.342 | 74.449 | 41.719 | 23.521 | 27.804 |
| Gross Profit Ratio
| 0.284 | 0.279 | 0.263 | 0.27 | 0.23 | 0.233 | 0.352 | 0.344 | 0.368 | 0.295 | 0.328 |
| Reseach & Development Expenses
| 82.165 | 45.192 | 30.139 | 22.315 | 22.938 | 24.096 | 38.257 | 0 | 0 | 0.002 | 0 |
| General & Administrative Expenses
| 16.985 | 18.188 | 11.579 | 9.957 | 7.681 | 20.355 | -9.681 | 16.094 | 4.589 | 0.927 | 0.952 |
| Selling & Marketing Expenses
| 1.71 | 3.123 | 1.652 | 1.612 | 2.288 | 1.332 | 1.689 | 2.657 | 1.98 | 1.338 | 1.301 |
| SG&A
| 18.695 | 21.311 | 13.231 | 11.569 | 9.969 | 21.687 | -7.992 | 18.751 | 6.569 | 2.265 | 2.253 |
| Other Expenses
| 54.71 | -2.604 | -1.959 | -3.031 | 0.196 | -2.146 | -0.766 | 0 | 0 | -0.647 | 0.824 |
| Operating Expenses
| 155.57 | 101.342 | 60.801 | 47.632 | 49.877 | 48.656 | 38.318 | 21.382 | 7.742 | 3.567 | 3.877 |
| Operating Income
| 733.482 | 273.832 | 154.534 | 100.592 | 65.732 | 58.394 | 74.076 | 53.303 | 34.143 | 21.397 | 23.786 |
| Operating Income Ratio
| 0.234 | 0.191 | 0.182 | 0.18 | 0.115 | 0.107 | 0.215 | 0.247 | 0.301 | 0.269 | 0.28 |
| Total Other Income Expenses Net
| -1.718 | -2.604 | -1.959 | -3.031 | 0.196 | -7.761 | -7.41 | -0.236 | 0.051 | 0 | -0 |
| Income Before Tax
| 731.763 | 271.228 | 152.576 | 97.562 | 65.928 | 56.248 | 73.311 | 53.066 | 33.977 | 21.397 | 23.785 |
| Income Before Tax Ratio
| 0.234 | 0.189 | 0.18 | 0.174 | 0.115 | 0.103 | 0.213 | 0.245 | 0.3 | 0.269 | 0.28 |
| Income Tax Expense
| 77.836 | 32.842 | 19.149 | 12.502 | 7.361 | 6.231 | 10.241 | 7.839 | 5.166 | 2.991 | 3.732 |
| Net Income
| 653.927 | 238.377 | 133.426 | 85.059 | 58.568 | 50.017 | 63.07 | 45.228 | 28.811 | 18.406 | 20.053 |
| Net Income Ratio
| 0.209 | 0.166 | 0.157 | 0.152 | 0.102 | 0.091 | 0.183 | 0.209 | 0.254 | 0.231 | 0.236 |
| EPS
| 3.4 | 1.24 | 0.69 | 0.44 | 0.3 | 0.35 | 0.44 | 0.75 | 0.48 | 1.31 | 1.44 |
| EPS Diluted
| 3.39 | 1.24 | 0.69 | 0.44 | 0.3 | 0.35 | 0.44 | 0.75 | 0.48 | 1.31 | 1.44 |
| EBITDA
| 810.24 | 330.164 | 203.269 | 129.172 | 93.721 | 81.666 | 81.34 | 57.415 | 34.876 | 22.1 | 24.853 |
| EBITDA Ratio
| 0.259 | 0.244 | 0.236 | 0.223 | 0.189 | 0.165 | 0.258 | 0.266 | 0.308 | 0.267 | 0.285 |